Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL137867 | 0.85 | GPR35 (0.38) | GPR35MAPTTSHRKDM4EALDH1A1 | |
| SCHEMBL19267322 | 0.84 | MAPT (0.34) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL19220752 | 0.84 | GPR35 (0.33) | GPR35MAPTTSHRKDM4EALDH1A1 | |
| SCHEMBL16553892 | 0.83 | GPR35 (0.37) | GPR35MAPTTSHRKDM4EALDH1A1 | |
| Bromide SCHEMBL2266333 | 0.83 | GPR35 (0.37) | GPR35MAPTTSHRKDM4EALDH1A1 | |
| SCHEMBL1158425 | 0.82 | GPR35 (0.45) | GPR35 | |
| SCHEMBL12688138 | 0.79 | GPR35 (0.43) | GPR35 | |
| SCHEMBL16256688 | 0.79 | GPR35 (0.43) | GPR35 | |
| SCHEMBL16256689 | 0.79 | GPR35 (0.43) | GPR35 | |
| Thiophene SCHEMBL1095087 | 0.76 | GPR35 (0.33) | GPR35MAPTTSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10707426-B2 | Liquid crystal photoalignment materials | LOMOX LIMITED (GB) | 2020-07-07 | — | — | US | disclosed |
| US-20170084846-A1 | Liquid Crystal Photoalignment Materials | LOMOX LTD (GB) | 2017-03-23 | — | — | US | disclosed |
| US-9508942-B2 | Liquid crystal photoalignment materials | LOMOX LIMITED | 2016-11-29 | — | — | US | disclosed |
| EP-2361444-B1 | CHARGE TRANSPORTING LIQUID CRYSTAL PHOTOALIGNMENT MATERIAL AND METHOD OF FORMING SAID MATERIAL | LOMOX LTD (GB) | 2016-01-27 | — | — | EP | disclosed |
| US-20110020566-A1 | Materials | LOMOX LIMITED (GB) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020566-A1 | Materials | VIM, EPCAM, S100A4 | GPR35 3771/4885MAPT 158/4885TSHR 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.